4
Changes in Ownership
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-21-010892
VP, Finance & Accounting sold 22,912 shares at an average $6.92 ($158,440)
- VP, Finance & Accounting acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Tessmer James F · VP, Finance & Accounting
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-15 | Sale : show line 1 in the form | −10,912 | $6.90 | $75,340 | 71,766 | D |
| 2021-03-15 | Exercise or conversion : show line 2 in the form | +12,000 | $3.31 | $39,720 | 83,766 | D |
| 2021-03-15 | Sale : show line 3 in the form | −12,000 | $6.93 | $83,100 | 71,766 | D |
| Open-market sales · 22,912 sh · avg $6.92 · $158,440 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-15 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −12,000 | $3.31 | 2030-02-06 | 12,000 | 50,980 | D |
Loading xslF345X03/form4.xml…